全文获取类型
收费全文 | 2425篇 |
免费 | 186篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 38篇 |
妇产科学 | 71篇 |
基础医学 | 109篇 |
口腔科学 | 20篇 |
临床医学 | 280篇 |
内科学 | 109篇 |
皮肤病学 | 12篇 |
神经病学 | 197篇 |
特种医学 | 24篇 |
外科学 | 147篇 |
综合类 | 1095篇 |
预防医学 | 203篇 |
眼科学 | 8篇 |
药学 | 86篇 |
12篇 | |
中国医学 | 174篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 34篇 |
2022年 | 82篇 |
2021年 | 89篇 |
2020年 | 65篇 |
2019年 | 72篇 |
2018年 | 72篇 |
2017年 | 83篇 |
2016年 | 83篇 |
2015年 | 71篇 |
2014年 | 213篇 |
2013年 | 210篇 |
2012年 | 201篇 |
2011年 | 212篇 |
2010年 | 168篇 |
2009年 | 163篇 |
2008年 | 167篇 |
2007年 | 178篇 |
2006年 | 175篇 |
2005年 | 97篇 |
2004年 | 64篇 |
2003年 | 43篇 |
2002年 | 29篇 |
2001年 | 9篇 |
2000年 | 19篇 |
1999年 | 9篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1985年 | 5篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1977年 | 2篇 |
排序方式: 共有2643条查询结果,搜索用时 15 毫秒
1.
【目的】 研究我国中文SCI科技期刊的现状,以期为其影响力提升和未来发展提供思考。【方法】 利用网站调研(期刊官网和Web of Science数据库等)、微信公众号运营情况查询及统计分析等方法对中文SCI科技期刊进行较全面的数据采集与分析。【结果】 18种中文SCI科技期刊有深厚的历史积淀和良好的发展基础,但整体上仍存在一些问题,如国内影响力不如优秀的纯中文期刊(国内影响力排名不够靠前),国际影响力不高(JCR分区仅为Q3或Q4区),国际化发展程度不够(国际编委占比为0的期刊高达11种,缺乏国际新媒体宣传),不够重视网络首发(仅9种期刊有网络首发)等。【结论】 在目前国内良好政策环境下,我国中文SCI科技期刊需要坚守初心,可根据各自期刊定位制定个性化发展策略,从而发展成为旗舰期刊甚至是世界一流期刊。 相似文献
2.
本文通过对《中医基本名词术语中英对照国际标准》和《WHO西太平洋地区传统医学名词术语国际标准》舌诊术语进行比较,分析两部标准中舌诊术语英译的优缺点,提出更适宜优先选择作为中医舌诊术语英译标准的方案,以期为中医名词术语标准化工作提供参考。 相似文献
3.
Rodziah AliNani DramanSiti Suhaila Mohd YusoffBachok Norsa’adah 《Asian Pacific journal of cancer prevention》2020,21(10):2971-2978
Objective: To determine the level of self-efficacy for coping with breast cancer among Malaysian women and its association with socio-demographic and clinical variables. Materials and Methods: This cross-sectional study involved 168 women diagnosed with breast cancer. The inclusion criteria were age >18 years old, having histologically confirmed breast cancer, and being diagnosed between January 1, 2009 to December 31, 2012. The exclusion criteria were being illiterate and having cognitive impairment. For data collection patients’ medical records and the Cancer Behaviour Inventory-Brief (CBI-B) Malay version questionnaire were used. Simple and multiple logistic regression methods were used to analyse the data. Results: Patients’ mean (SD) age was 51.4 (10.8) years old. Most of the patients were Malays, married, diagnosed at stage 2 breast cancer (41%), and completed their breast cancer treatment. The mean score for self-efficacy for coping with breast cancer was 83.67 (95% CI: 81.87, 85.47). The significant factors positively correlated with self-efficacy for coping with breast cancer were higher educational background and a higher family income. However, factors such as a family history of breast cancer and breast surgery reduced the mean score of self-efficacy for coping with breast cancer. Conclusion: The mean score of self-efficacy for coping with breast cancer in this study was moderate. Self-efficacy for coping with breast cancer in Hospital Universiti Sains Malaysia was not adequate among sufferers and improvement is needed probably by providing education to these patients. 相似文献
4.
5.
目的验证中文版胃肠神经内分泌肿瘤患者生活质量量表(QLQ-GI.NET21)的信度及效度。方法在征得欧洲癌症治疗研究组织同意后,获得原始量表。邀请国内6名医护专家对量表内容进行评分,计算内容效度。应用癌症患者生存质量核心量表(QLQ-C30)和QLQ-GI.NET21分别对235例胃肠神经内分泌肿瘤患者进行问卷调查。并于2周后随机抽取60例进行再次问卷调查。结果共回收有效问卷220份,46例完成2周后的重测。QLQ-GI.NET21总量表内部一致性信度0.913;重测信度为0.899;内容效度指数为0.889;与QLQ-C30量表总分的相关性为0.417(P0.01),探索性因子分析提取出5个公因子,累积贡献率63.10%,具有良好的结构效度。该量表各条目有良好的区分度(P0.05)。结论中文版QLQ-GI.NET21量表具有良好的信效度,可用于胃肠神经内分泌肿瘤患者生活质量的测评。 相似文献
6.
7.
8.
《Neurología (Barcelona, Spain)》2020,35(5):303-310
IntroductionThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is frequently used in clinical practice to evaluate cognitive function. It is quick to administer (20-30 minutes) and is not influenced by a learning effect. The RBANS includes 4 parallel versions and has a high discriminative ability.Our study provides normative data from the RBANS-E (Spanish-language version of RBANS form A) for a Spanish population aged 20 to 89 years.MethodsThe study included 609 subjects aged 20 to 89 years. Participants were evaluated at baseline with a short interview, a cognitive screening test (Mini–Mental State Examination), and a functional scale (Rapid Disability Rating Scale). The RBANS-E was then administered to all 609 participants.ResultsOur results show the influence of education on all subtest scores. Sex was observed to have no impact on any subtest.ConclusionOur study provides highly useful normative data for the cognitive evaluation of young and adult populations. 相似文献
9.
10.
《Sleep medicine》2021
BackgroundFew treatments are available for patients with idiopathic hypersomnia (IH). Modafinil, an established treatment for narcolepsy, was tested for efficacy and safety in Japanese patients with IH without long sleep time.MethodsThis multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study was conducted at 20 institutions in Japan. Patients who met the diagnostic criteria of IH in the International Classification of Sleep Disorders (second edition) were included. The study comprised a ≥17-day observation period and a 3-week treatment period during which modafinil (200 mg) or placebo was administered orally once daily (in the morning). The primary efficacy endpoint was change in mean sleep latency on the Maintenance of Wakefulness Test (MWT). Adverse events (AEs) were also recorded to evaluate safety.ResultsIn total, 123 patients were screened and 71 were randomized to receive modafinil (N = 34) or placebo (N = 37). Patients treated with modafinil experienced a significantly prolonged mean sleep latency on the MWT at the end of the study compared with placebo (5.02 min, 95% confidence interval: 3.26–6.77 min; p < 0.001). AEs occurred in 58.8% (20/34) and 27.0% (10/37) of patients in the modafinil and placebo groups, respectively. Frequent AEs in the modafinil group were headache (n = 6), dry mouth (n = 3), and nausea (n = 3); no clinically significant AEs occurred.ConclusionModafinil was shown to be an effective and safe treatment for excessive daytime sleepiness in patients with IH without long sleep time.Clinical trial registrationJapicCTI; 142539. 相似文献